Streptococcus pneumoniae isolates of serotypes 1, 4, 6B, 7F, 14, and 19F belonging to clonal types with known invasive disease potential in humans were used to infect C57BL/6 and BALB/c mice. Most isolates were able to colonize the nasopharynx for 7 days. One serotype 19F isolate of the clonal type ST162 had higher bacterial numbers than other isolates and clonal types of the same serotype. Serotype 4 clones caused the most-severe invasive disease, whereas serotype 1 clones caused low-level bacteremia without disease symptoms. BALB/c mice were more likely than C57BL/6 mice to develop meningitis. Disease kinetics varied significantly between clonal types. Although most induced a robust tumor necrosis factor response, some isolates of serotype 1 and 7F did not, suggesting that invasive disease caused by different clonal types may result in different degrees of host response. Capsular serotype, other clonal properties, and host factors are important for the development of pneumococcal disease.
Some capsular serotypes of Streptococcus pneumoniaesuch as 1, 4, and 7F-are primarily found in patients with invasive disease and are rarely found in healthy carriers, whereas other serotypes-such as 6B, 14, 19F, and 23F-are frequent colonizers in the nasopharynx of healthy preschool children but also may cause invasive disease. Also, particular serotypes-such as 3, 6B, and 19F-are more often associated with severe invasive disease and mortality in humans than are other serotypes-such as 1 and 7F [1] [2] [3] [4] . The pneumococcal capsule provides an antiphagocytic property to the bacterium, and it is likely that different capsular polysaccharides induce different degrees of antiphagocytic re-sponses. Furthermore, capsular polysaccharides may be recognized by C-type lectins in the spleen, and this recognition promotes clearance of the bacteria from the bloodstream [5] . It is possible that different capsular chemistries affect the interaction with these lectins. Therefore, the capsular polysaccharides act as dominant virulence factors in pneumococci, and epidemiological studies have suggested that the capsular serotype, rather than other clonal properties, determines the potential attack rate of the baterium [6, 7] . However, in a study comparing carrier and invasive isolates from the Stockholm area during a 1-year period, we identified clones of the same serotype that differed in their occurrence in carriers, compared with their occurrence in patients with invasive disease, and their ability to cause invasive disease, and this finding suggests that clonal properties other than capsular serotype also affect the ability of the bacterium to cause invasive disease in humans. These clonal differences may be diverse, such as variation in the distribution and composition of horizontally acquired pathogenicity islands [8] .
Because variation in host susceptibility is not taken into account when the attack rate of pneumococci is assessed in an epidemiological study, such studies need to be complemented by infection studies in inbred mice. In the present study, we examined inbred mice after [6] ; information on clones was obtained in our previous study [4] . b Not tested with the light-sensitive camera, because of a problem with transformation of the luciferase cassette.
intranasal (inl) or intraperitoneal (ip) challenge with 13 isolates belonging to 10 clonal types of serotypes 1, 4, 6B, 7F, 14, and 19F with known odds ratios (ORs) for invasiveness [4] . Our results verify that the capsular serotype is important for disease outcome but that other clonal properties influence colonization and the invasive disease potential to a significant extent. Furthermore, disease severity in humans was related to the degree of proinflammatory response in mice. Finally, our data suggest that the ability of the pneumococci to cause meningitis, the most severe form of invasive pneumococcal disease, depends to a significant degree on host factors.
MATERIALS AND METHODS
Bacterial strains used. The pneumococcal strains used were the sequenced S. pneumoniae invasive TIGR4 strain and 13 clinical pneumococcal isolates selected to provide a wide range of clones with different abilities to cause invasive disease in humans (table 1) . These clones were identified in 2 previous molecular epidemiological studies in which we compared nasopharyngeal isolates from healthy children with invasive isolates from the Stockholm area obtained during the same year and thereby were able to obtain estimates on ORs for invasiveness for a number of clones [4, 9] . Creation of bioluminescent derivatives of the clinical isolates. Stable bioluminescent derivatives of the clinical isolates were created using chromosomal DNA from the highly bioluminescent S. pneumoniae strain D39 Xen 7. D39 Xen 7 carries the Tn4001 luxABCDE Km r cassette, as described elsewhere [10, 11] . This results in production of luciferase and its substrate and emission of light, which is monitored in mice with a charge-coupled device camera (Xenogen). Transformants were selected on blood plates containing kanamycin (400 mg/ mL) and were grown at 37ЊC in 5% CO 2 .
Experimental pneumonia and sepsis model in mice. Experiments performed in Memphis, Tennessee, were approved by the Animal Care and Use Committee at the St. Jude Children's Research Hospital. Female BALB/c and C57BL/6 mice, 4-5 weeks old, were obtained from Jackson Laboratory. Experiments performed in Stockholm, Sweden, were approved by the Ethical Committee for Animal Experiments in Stockholm and were conducted in accordance with the European Communities Council Directive 86/609/EEC. Female C57BL/6 mice, 4-6 weeks old, were bred and housed in the animal facility of the Microbiology and Tumor Biology Center at the Karolinska Institute (Stockholm, Sweden). All mice were kept on a 12-h light-dark cycle and had access to standard food and tap water as desired.
Mice were anesthetized by light inhalation of isoflurane (Forene; Abbott) and were inoculated either ip or inl with live S. pneumoniae ( cfu), grown in C+Y medium [12] , in a 6 ∼ 5 ϫ 10 volume of 200 mL or 20 mL, respectively. For ip experiments, the original pneumococcal strains were used, and for inl experiments, the created bioluminescent strains were used. Most strains without bioluminescence were also tested in the inl model (data not shown). We found no evidence that the lux gene has an effect on virulence. Mice were monitored for 7 days to assess their health status, and each day they were given a clinical score for disease severity. Disease severity was graded on a scale of 0-5, with 0 meaning the mouse was healthy and exhibited normal motor activity, 1 meaning the mouse showed decreased spontaneous activity and a hunched posture, 2 meaning the mouse had tremor and piloerection and loss of vigilance, 3 meaning the mouse turned upright in 15 s after being inverted, 4 meaning the mouse had positional passivity and did not turn upright after being inverted, and 5 meaning the mouse did not move. A mouse was considered to have meningitis if it presented with clinical symptoms, including ataxia and imbalance, combined with bioluminescence from the skull. Mice were killed at 72 h or 168 h after challenge or when they had a disease severity score 13. In the experiments on short-time kinetics after ip challenge, mice were killed randomly at 4 or 6 h after challenge. . The same 5 mice in each group were followed throughout the entire experiment. Because of the fur color, bioluminescence signals in the C57BL/6 mice are lower in intensity than those in the BALB/c mice. The pictures were composed so that slightly more of the background can be seen behind the C57BL/6 mice than behind the BALB/c mice.
Distribution and quantification of bacteria in mice and determination of tumor necrosis factor (TNF) in blood.
To monitor bioluminescent S. pneumoniae infections, mice were anesthetized with isoflurane and imaged at different time points after challenge, by use of the IVIS Imaging System 100 Series (Xenogen). Blood was collected, serially diluted in PBS, and plated on blood agar plates. Bacteremia was estimated from the number of colony-forming units found per milliliter of blood. Bacterial burden of the lungs was estimated from the number of colony-forming units found per gram of homogenized lung tissue. Nasopharyngeal-tracheal lavage samples were obtained by flushing 0.2 mL of PBS through the tracheas of dead mice and collecting the first 10-20 mL of liquid that could be extracted from the nares. Colonization in the nasopharynx was estimated from the number of colony-forming units found per milliliter of nasopharyngeal-tracheal lavage samples. TNF was measured in mouse serum using commercial ELISA kits (R&D Systems) at 4 and 6 h after ip challenge.
Data analysis. For survival studies, differences were analyzed by the Kaplan-Meier log-rank test. Data on colony-forming units in blood after ip challenge and TNF responses were analyzed using Student's t test. For measurements of bioluminescence, Living Image software (version 2.50; Xenogen) was used, and comparisons were made with Student's t test. For comparisons of frequencies, Fisher's exact test was used. P ! was considered to be statistically significant. .05
RESULTS
Clonal and serotype-specific properties in colonization and frequency of invasive disease. Representatives of pneumococcal clones belonging to 6 serotypes (table 1) that have known ORs for invasiveness [4] were genetically tagged with the lux gene and inoculated into C57BL/6 and BALB/c mice.
Colonization after inl challenge. All but 3 of the pneumococcal isolates colonized 100% of the C57BL/6 and BALB/ c mice at 168 h after challenge (data not shown), as monitored by measurement of colony-forming units in nasopharyngealtracheal lavage samples. The exceptions were ST228 1 , ST306 1 , and ST124
14
, which had a weak ability to colonize. Identification of a hypercolonizing 19F clone. Three isolates of serotype 19F belonging to 2 different clonal types were tested for colonization in the inl mouse model. Tracking of bacteria using bioluminescence showed that the invasive and carrier isolates of ST162
19F had a remarkably strong ability to colonize both the C57BL/6 and the BALB/c mice, a trait not found for the other clone (ST425 19F ) ( figure 1A and 1B) . In mice infected with ST162 19F , the intensity of bioluminescence from the nose increased during the first 7 days after challenge. The intensity remained unchanged through day 9 and disappeared by day 16 after challenge. In BALB/c mice, at day 7 after challenge, the mean radiance was 1291 photons/s/cm 2 /steradian (photons per second leaving a square centimeter radiating into an angle of 1 steradian) for those infected with ST162
19F and was Ϫ361 photons/s/cm 2 /steradian (i.e., no detectable emission of light) for those infected with ST425 19F ( ). In C57BL/ P ! .005 6 mice, the mean radiance was 497 and 70 photons/s/cm 2 / steradian, respectively ( ). Calculation of radiance was P p .053 normalized to the background radiance of the mice, so negative values were possible. We confirmed the bioluminescence data by obtaining nasopharyngeal-tracheal lavage samples from mice at day 7 or day 28 after challenge, and bacteria were found in the nasopharynx at both time points (data not shown). A mean of cfu/mL was found in the C57BL/6 mice challenged 6 1 ϫ 10 with ST162
19F
, compared with a mean of cfu/mL in the 4 5 ϫ 10 C57BL/6 mice challenged with ST425
19F . Similar differences were found in the BALB/c mice (data not shown).
Pneumonia, bacteremia, and survival after inl challenge. In C57BL/6 mice, the 2 ST205 4 isolates were the most able to cause lethal systemic disease after inl challenge, and ST138 6B was the next most able ( figure 2A) . Members of these 2 clonal types were the only isolates that caused high levels of bacteremia and death ( figure 2A and 2B) . Once bacteremia was established, the mice were unable to clear ST205 4 infection and died of septicemia, whereas clearance of bacteria was evident in infection with ST138
6B
. Thus, whereas most mice infected with ST138
6B were bacteremic at 24 h after challenge, no mouse was bacteremic at 168 h after challenge, and no mouse died 148 h after challenge ( figure 2A and 2B) .
Clones causing systemic disease (ST205 4 and ST138
) also caused pneumonia, as was revealed by the observation of colonyforming units in lung tissue ( figure 2C) . However, at 168 h after figure  2C ). The invasive ST307 14 isolate caused pneumonia in 20% of mice, whereas the carrier ST555 14 isolate did not cause pneumonia in any mouse. Although the majority of mice infected with ST162
19F developed pneumonia (figure 2C), few developed bacteremia (figure 2B), which is in accordance with the results of previous studies [13] [14] [15] .
The susceptibility to pneumococcal infections and disease patterns in C57BL/6 and BALB/c mice. Differences in disease outcome after pneumococcal challenge are not solely due to the genetic makeup of the pathogen but also reflect differences in host susceptibility. The isolates studied were tested in both C57BL/6 and BALB/c mice, because previous studies showed that different mice may have different susceptibilities to bacterial infections [16, 17] . BALB/c mice were more resistant to infections with the most virulent clone used (ST205 4 ) (table 2 and figure 3A) . After inl challenge with the ST205 4 isolates, C57BL/6 mice showed slightly (but not significantly) higher rates of pneumonia and more-severe bacteremia than BALB/c mice up to 72 h after challenge ( ). As a result of having P ! .05 less-severe bacteremia, BALB/c mice developed signs of disease later than C57BL/6 mice did, and, at 168 h after challenge, BALB/c mice had bacteremia and showed symptoms of disease (table 2 and figure 3A) . For BALB/c and C57BL/6 mice, 25% of the mice were alive at 168 h and 96 h after challenge, respectively. BALB/c mice also had a tendency toward higher survival at 1168 h after challenge ( ; ), and some 2 x p 1.6 P p .21 BALB/c mice were still bacteremic at this time point, whereas the surviving C57BL/6 mice were not (tables 2 and 3). A striking finding was that BALB/c mice were more likely than C57BL/6 mice to develop meningitis (table 2 and figure  3B ). Of the BALB/c mice, 19% (4/21) developed meningitis after inl challenge with the ST205 4 isolates (table 2 and figure  3B ), compared with !2% (1/45) of the C57BL/6 mice (P ! .05). Also, ST138
6B was more likely to cause meningitis in BALB/c mice than in C57BL/6 mice (data not shown).
In contrast, BALB/c mice showed an increased susceptibility to pneumonia after inl challenge with ST555 14 , compared with C57BL/6 mice. Of the BALB/c mice, 50% (5/10) developed pneumonia, whereas none (0/15) of the C57BL/6 mice had developed pneumonia by 168 h after challenge ( ). Furthermore, P ! .05 BALB/c mice showed a tendency to be more susceptible to ST138 6B infection than C57BL/6 mice: only 70% (7/10) of the BALB/c mice were alive at 168 h after challenge, compared with 93% (14/15) of the C57BL/6 mice ( ; ).
2 x p 2.1 P p .15 Different TNF responses in C57BL/6 mice after ip challenge. There were large differences between serotypes and between clones in their abilities to grow in blood, to mount an inflammatory response, and to cause death in C57BL/6 mice after ip challenge ( figure 4A-C) . As was expected, the most virulent isolates after inl challenge (those of ST205 4 ) were also highly virulent after ip challenge. Members of this clonal type induced high levels of bacteremia and high levels of TNF in plasma ( figure 4A and 4B) . Signs of disease were seen at 6 h after challenge. Fatal sepsis led to a median survival time of 14 h ( figure 4C ). ST138 6B and ST176 6B showed a similar pattern of rapid, fatal septicemia that was associated with high levels of TNF. Both ST425 19F and ST162 19F induced an increased TNF response, but the TNF response in mice at 6 h after challenge was much stronger with the hypercolonizing ST162
19F isolate than with ST425 19F ( ) ( figure 4B ). The level of bacter-P ! .0001 emia was only slightly lower after challenge with ST425
19F than with ST162
19F (median, vs. cfu/mL of 6 6 3.60 ϫ 10 9.40 ϫ 10 blood at 4 h after challenge [ ] and vs. 5.00 7 P p .41 2.00 ϫ 10 ϫ 10 7 cfu/mL of blood at 6 h after challenge [ ]), and P p .79 the growth rate was the same for both clones ( figure 4A) figure 4B ), even though the number of bacteria in the bloodstream was relatively high. The number of colonyforming units in blood remained unchanged between 4 and 6 h after challenge with the ST191 7F isolates, which suggests that there was an effective clearing of bacteria from the host even in the absence of a TNF response. However, eventually all mice developed fatal sepsis within 40 h after challenge with these isolates, with a median survival time of 17 h. The median survival times for the C57BL/6 mice infected with ST228 1 and ST306 1 were 44 h and 168 h, respectively (x 2 p 34.21; ) ( figure 4C ). There were also significant differences in P ! .05 the overall survival rate after 168 h: 0% after challenge with the ST228 1 clone and 32% after challenge with the ST306 1 clone. This finding exemplifies that isolates of the same serotype but of a different clonal type may differ in their ability to escape the process of host clearance during systemic infection. ST124 14 and ST555 14 were the least virulent isolates after ip challenge ( figure 4C ). ST124 14 induced a low level of bacteremia that correlated to no TNF response at 4 and 6 h after challenge (figure 4B). The survival rate was 50%, with a median survival time of 143 h. ST555
14 was less virulent, with a 90% survival rate and a median survival time of 1216 h ( ; ) 2 x p 3.9 P ! .05 ( figure 4C ).
DISCUSSION
We have recently shown that pneumococci belonging to different serotypes and clones can be divided into 3 major groups on the basis of their ability to cause invasive disease in humans [4] . The first group includes serotypes most commonly found in invasive disease and rarely found in carriers-such as serotypes 1, 4, and 7F-that have a high invasive disease potential. Although mortality in humans has been shown to be very low (∼0%) for infections with serotype 1 and serotype 7F isolates, it has been demonstrated to be intermediate to high (10%) for infections with serotype 4 isolates [1, 18] . The second group includes serotypes commonly found both in invasive disease and in carriers-such as serotypes 14 and 6B-that have an intermediate invasive disease potential. Invasive disease attributed to infection with serotypes 14 and 6B isolates has been associated with intermediate (7%) and high (25%) mortality, respectively [1] . The third group includes serotypes primarily found in carriers-such as serotype 19F-that have a low invasive disease potential. Isolates belonging to this serotype were commonly found in carriers at Stockholm day care centers. In- vasive 19F isolates from the same region were found relatively infrequently. Nevertheless, invasive disease mediated by serotype 19F has been associated with high APACHE scores and high mortality (25%) [1] . It is possible that pneumococcal variants that exhibit a high attack rate (first group) are more likely than opportunists (third group) to affect healthy individuals, and this explains why, for example, septicemia caused by a serotype 1 isolate usually is milder than that caused by a serotype 19F isolate. Alternatively-or in addition-host responses to different pneumococcal serotypes may differ significantly, and this difference in response can affect both the likelihood of developing invasive disease and disease severity.
Even though capsular polysaccharides represent a major pneumococcal virulence factor, we do not know to what extent the significant differences in invasive disease potential and severity that we and others [4, 6, 19] found for different serotypes are due to the capsule itself and/or to the closer genetic relationship that likely prevails for isolates of the same serotype. In our previous epidemiological study, we found several isolates of the same serotype but of different clonal types that differed in their ability to cause invasive disease. Also, isolates belonging to the same clonal type but of different serotypes, due to serotype switches, were found to have similar ORs for invasiveness [4] .
In the present study, we infected C57BL/6 and BALB/c mice with a collection of isolates belonging to pneumococcal clonal types and serotypes with known ORs for invasiveness, as determined in our previous study [4] . Our data demonstrate significant differences in virulence not only between different serotypes but also between different clonal types of the same serotype. In addition, our data highlight the importance of host factors in disease outcome. The ST205 4 isolates were the only ones to cause significant mortality after inl challenge. ST205 is a serotype 4 clone that is a common cause of invasive disease in humans in several countries and is rarely seen in healthy carriers. TIGR4, isolated in Norway, seemed to be more likely to cause pneumonia in mice than the Stockholm isolate belonging to the same clonal type ( figure 2C ). Whether this difference is due to the presence of the virulence-associated rlrA locus in TIGR4 [20] that is not present in the Stockholm isolate remains to be determined. Nearly all other clonal representatives used in the present study were unable to cause lethal invasive disease in mice, and only a limited number caused bacteremia after inl challenge. All mice died after ST205 4 reached the bloodstream, whereas in infection with other clonal types, mice were able to clear the bacteria. One notable example was ST228 1 . This serotype 1 clone caused low-level bacteremia over a long period but did not cause serious disease.
Our findings that BALB/c mice were less susceptible to the most virulent isolates (those of ST205 4 ) than were C57BL/6 mice but were more susceptible to some of the less virulent clones (those of serotypes 6B and 14) reveal the central importance of host responses in the likelihood of developing disease. It is likely that human polymorphisms in host defense functions affect the susceptibility to disease caused by different clonal types. Not only the likelihood of developing disease but also the type of disease might be host dependent. Particularly interesting in this respect was our finding that BALB/c mice were more likely to develop meningitis after challenge with the ST205 4 and ST138 6B isolates than were C57BL/6 mice. The slower progression of invasive disease and the prolonged period of bacteremia in BALB/c mice might be contributing factors in increasing the likelihood of developing meningitis. A slow progression of systemic disease might, for example, allow time for a more direct transmission of bacteria from the nasopharynx to the meninges [21] .
Invasive pneumococcal disease in humans is likely preceded by a colonization phase in the nasopharynx. Little is known about bacterial and host factors that affect colonization. Our mice experiments show that there are significant differences between different clonal types and their ability to colonize. Most notable was our finding of a hypercolonizing 19F isolate belonging to clonal type ST162, a clone frequently found in carriers in the Stockholm area. This isolate appeared to be a hypercolonizer in both C57BL/6 and BALB/c mice, and the phenotype expressed seemed independent of the 19F capsule, because a 19F isolate of a different clonal type did not exhibit this phenotype. Of the 19F isolates, only the hypercolonizing ST162
19F isolate was able to reach the bloodstream from the nasopharynx, albeit it did so transiently and at low numbers. Hence, the number of bacteria in the nasopharynx is likely to be an important parameter that affects the likelihood of developing invasive disease.
Interestingly, ip challenge with the serotype 1 and 7F isolates caused virtually no TNF response in mice. These serotypes, which are not included in the 7-valent conjugated pneumococcal vaccine, have been associated with low mortality and low APACHE scores in human systemic pneumococcal disease [1] , and preliminary data suggest that they might act as primary pathogens in previously healthy individuals (K. Sjöström, C. Spindler, Å . Ö rtqvist, M. Kalin, A. Sandgren, and B. HenriquesNormark, unpublished data). In contrast, clonal types of serotypes 6B and 19F, which are associated with significant mortality in humans, caused a significant TNF response. Our data presented here, together with clinical data, therefore suggest that pneumococci of different clonal types might cause systemic disease via different mechanisms.
